“biogen” Archives

in
Entry Author Date Location
Ed Kaye on Sarepta’s Duchenne Quest, Rising to CEO & His New Startup 11/20/17 Boston
Bio Roundup: CBO’s Praise, Celgene’s Shock, Trump’s Opioid Plan & More 10/27/17 National
Vir Biotech Vies for Global Approach to Tackling Infectious Disease 10/18/17 San Francisco
Celebrating Boston Life Sciences: Xconomy Awards Gala Slideshow 10/03/17 Boston
The Winners of the 2017 Xconomy Awards Are… 09/26/17 Boston
Bio Roundup: RNAi’s Big Day, CAR-T For Kids, Drugs From Fungi & More 09/22/17 National
Alnylam Data Puts a Nobel Discovery One Step Closer to Approved Drug 09/20/17 Boston
After Biogen Deal Fizzles, Rodin Bags $27M And Heads To First Trial 09/18/17 Boston
Breaking Barriers & Building Bridges: Xconomy’s Diversity Award Finalists 08/23/17 Boston
Alzeca Receives $11M for Early Alzheimer’s Detection Technology 08/17/17 Texas
Bio Roundup: GOP Drama, Immunotherapy Setbacks, Pharma Revamps 07/28/17 National
Biogen, Opening Bottlenecks, Sees Spine Drug Sales, Shares Rise 07/25/17 Boston
Syntimmune Snares $50M to Test Autoimmune Drug in Two Rare Diseases 06/21/17 New York
Alzheimer’s Drug Pipeline Analysis: Have We Hit Peak Amyloid? 06/21/17 National
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
Bio Roundup: Skinny Cuts, Genomic Approvals, Unfrozen FDA & More 05/26/17 National
Not Resting on Hemophilia Biz, Bioverativ Pays $400M For True North 05/23/17 Boston
Celgene’s Data Could Lead To New Option For Multiple Sclerosis Patients 05/22/17 New York
With Latest Deal, Biogen Bets $120M on Remedy Pharma Stroke Drug 05/15/17 Boston
Bio Leaders Mourn Passing of Genzyme Exec, Orphan Drug Innovator Termeer 05/14/17 Boston
Last Chance to Snag a Ticket for What’s Hot in Boston Biotech 05/10/17 Boston
Grab Your Ticket for What’s Hot in Boston Biotech on May 11th 05/03/17 Boston
FDA Approves BioMarin Drug, A First for Rare Genetic Batten Disease 04/27/17 San Francisco
Duchenne, SMA, and the Rise of Patient Power at “What’s Hot” on May 11 04/27/17 Boston
Will New Data Open “Bottlenecks” For Biogen’s Pricey Spine Drug? 04/26/17 Boston
Bio Roundup: Spinraza Woes, Science March, Baseline Launch & More 04/21/17 National
Phoenix Shops Its Cancer Drug as Potential Alzheimer’s Treatment 04/20/17 Texas
“Our Son’s Fate”: Parents Fighting for Kids’ Spine Drug Eye New Data 04/20/17 Boston
Bio Roundup: CRISPR Appeal, Bristol Deals, Stock Pumping & More 04/14/17 National
On Tap For “What’s Hot” on May 11: Opioid Crisis, Immigration & More 04/13/17 Boston
Page 1 of 7 next page »